Price $19.41 |
Market Cap
864.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
5.8
|
P/B
1.41
|
P/S
3.05
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
8.8
|
Op. Cash Flow
116.7K
|
FCF
1.5
|
|
Op. Margin
34.60%
|
Net Margin
17.20%
|
ROE
8.60%
|
ROI
34.90%
|
|
ROA
4.30%
|
EPS Growth
-80.20%
|
Current Ratio
3.3
|
Debt/Equity
78.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Myomo Inc (MYO) | $3.77 | - | - | 35.8M | Strong Buy |
| iCAD Inc (ICAD) | $1.51 | - | - | 38.2M | Strong Buy |
| PetIQ Inc (PETQ) | $30.58 | - | - | 564.3M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $2.73 | - | - | 183.6M | Strong Buy |
| Generation Bio Co (GBIO) | $2.32 | - | - | 65.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
